Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Prematurity; Extreme: full-pipeline trial registry
1 of 5 indexed Prematurity; Extreme trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Prematurity; Extreme: 5 US clinical trials tracked, 1 recruiting.
Prematurity; Extreme is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Alabama at Birmingham, running 2 of these trials.
Enrollment posture brief
Registry condition prematurity-extreme
OPEN 1 | RECR 20% | LATE 1 | EARLY 1 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Prematurity; Extreme lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Prematurity; Extreme on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Prematurity; Extreme is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Prematurity; Extreme research.
University of Alabama at Birmingham accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Prematurity; Extreme enrolment sits around 126 participants.
Median target enrolment is 126 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Prematurity; Extreme research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Targeted Fortification of Donor Breast Milk in Preterm Infants
Columbia University
NCT04294368
The Budesonide in Babies (BiB) Trial
NICHD Neonatal Research Network
NCT04545866
Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk
University of Alabama at Birmingham
NCT04325308
Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm
University of Alabama at Birmingham
NCT05615311
Use of NIRS in Preterm Population Born at Altitude
University of New Mexi
NCT04639583
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Prematurity; Extreme records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Prematurity; Extreme trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Prematurity; Extreme page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Prematurity; Extreme trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Alabama at Birmingham sponsors the most Prematurity; Extreme trials on record, review their full trial history before evaluating a specific study. See University of Alabama at Birmingham's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Prematurity; Extreme condition card totals 5 registered trials; most-linked intervention Near-infrared spectroscopy (NIRS) utilization; top US site state Alabama. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.